News Home

Moderna Inc (MRNA) Down 1.09% in Premarket Trading

Thursday, January 13, 2022 08:36 AM | InvestorsObserver Analysts
Moderna Inc (MRNA) Down 1.09% in Premarket Trading

Moderna Inc (MRNA) is down Thursday morning, with the stock decreasing -1.09% in pre-market trading to 220.45. MRNA's short-term technical score of 68 indicates that the stock has traded more bullishly over the last month than 68% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 93% of stocks. Moderna Inc has fallen 18.05% over the past month, closing at $282.02 on December 16. During this period of time, the stock fell as low as $213.86 and as high as $321.31. MRNA has an average analyst recommendation of Buy. The company has an average price target of $257.23.

Overall Score - 49
MRNA has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on MRNA!
Moderna Inc has a Long-Term Technical rank of 39. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 61% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, MRNA ranks better than 76% of stocks.

Important Dates for Investors in MRNA:

-Moderna Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $16.30. -We do not have a set dividend date for Moderna Inc at this time. Click Here To Get The Full Report on Moderna Inc (MRNA)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App